Medivation Names Rick Bierly Chief Financial Officer
March 31 2014 - 4:10PM
Marketwired
Medivation Names Rick Bierly Chief Financial Officer
SAN FRANCISCO, CA--(Marketwired - Mar 31, 2014) - Medivation,
Inc. (NASDAQ: MDVN) today announced the appointment of Rick Bierly
as chief financial officer, effective March 31, 2014. Rick will
serve as Medivation's principal financial and accounting officer
and will report to David Hung, M.D., president and chief executive
officer.
As previously announced, after more than 10 years as
Medivation's chief business and financial officer, Patrick Machado
is retiring from his position.
"Pat's contributions to our success have been invaluable as
we've grown from a small start up into a commercial organization
with a product approved in over 35 countries around the world. We
are extremely fortunate to have his help as Medivation transitions
to a new CFO," said David Hung, M.D., president and chief executive
officer of Medivation. "Rick brings many years of deep and varied
financial expertise in the Life Sciences industry and will be an
asset to Medivation as we continue to grow our business to capture
new opportunities. On behalf of the board and the other members of
the executive team, it is a pleasure to welcome Rick to
Medivation."
Rick Bierly added, "This is an exciting time to be joining
Medivation as the company looks to expand its XTANDI®
(enzalutamide) franchise and invest in new programs in areas
of unmet medical need. I look forward to working closely with the
Medivation team to achieve the organization's growth goals."
Rick Bierly brings to Medivation over 30 years' experience in
finance roles at Glaxo-SmithKline, Aventis, Centocor and Johnson
& Johnson. Among these roles were biotechnology CFO,
diagnostics CFO, Treasurer, External Reporting director, head of
shared services and operational finance roles in support of sales,
marketing, supply chain and R&D. He began his career in public
accounting at Ernst & Young (EY), and most recently served as
an executive director in EY's Financial Accounting Advisory
Services practice. Rick holds a Bachelor of Business Administration
degree from Pennsylvania State University and is a CPA in PA and
NJ.
About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the
rapid development of novel therapies to treat serious diseases for
which there are limited treatment options. Medivation aims to
transform the treatment of these diseases and offer hope to
critically ill patients and their families. For more information,
please visit us at www.medivation.com.
Contacts: Anne Bowdidge Sr. Director, Investor Relations (650)
218-6900
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medivation, Inc. (MM) (NASDAQ:MDVN)
Historical Stock Chart
From Apr 2023 to Apr 2024